The Biotechnology, Pharmaceutical and Medical technology industries continue their transformation to align to the evolving patient-driven care model plus mounting cost and regulatory pressures. While the focus has been on optimizing the manufacturing operations, Life Sciences organizations need to go further to optimize R&D, sales and distribution operations.
The move to patient-centric and outcome-based care.